Logo image of GENX.CA

GENIX PHARMACEUTICALS CORP (GENX.CA) Stock Price, Forecast & Analysis

Canada - TSX-V:GENX - CA37232A1093 - Common Stock

0.03 CAD
0 (0%)
Last: 11/5/2025, 7:00:00 PM

GENX.CA Key Statistics, Chart & Performance

Key Statistics
Market Cap1.84M
Revenue(TTM)100
Net Income(TTM)-88.80K
Shares61.22M
Float33.55M
52 Week High0.09
52 Week Low0.02
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)0
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO1996-06-25
Sector
GICS SectorConsumer Staples
GICS IndustryPersonal Care Products
GICS IndustryGroupHousehold & Personal Products
GICS SubIndustryPersonal Care Products


GENX.CA short term performance overview.The bars show the price performance of GENX.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60

GENX.CA long term performance overview.The bars show the price performance of GENX.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of GENX.CA is 0.03 CAD. In the past month the price decreased by -14.29%. In the past year, price decreased by -25%.

GENIX PHARMACEUTICALS CORP / GENX Daily stock chart

GENX.CA Latest News, Press Relases and Analysis

6 years ago - By: Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions
6 years ago - By: Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions

GENX.CA Competitors/Peers

The largest stocks on the Canadian markets in the "Personal Care Products" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
JWEL.CA JAMIESON WELLNESS INC 22.02 1.48B
LOVE.CA CANNARA BIOTECH INC 9.53 153.74M
VPI.CA VITALITY PRODUCTS INC N/A 1.24M
HILL.CA HILL STREET BEVERAGE CO INC N/A 557.60K

About GENX.CA

Company Profile

GENX logo image Genix Pharmaceuticals Corp. engages in the the research, development, manufacture, licensing and sales of novel and innovative healthcare products, particularly proprietary over the counter nutraceuticals and generic pharmaceuticals. The company is headquartered in Vancouver, British Columbia. The firm is a formulator, manufacturer, licensor and marketer of life sciences-related products with a focus on nutraceuticals and pharmaceuticals. Its operations consist primarily of the research, development, manufacture, in-licensing and sales of novel and healthcare products, focusing on proprietary over the counter (OTC) nutraceuticals and generic pharmaceuticals. The firm has been marketing and selling other nutraceuticals and some pharmaceutical products, such as bee propolis capsules, calcium liquid softgels, seal oil softgels, marine lipid softgels, Lecithin softgels, fish oil softgels, EPO softgels and spirulina powder. Its products include Ketorolac 0.5% Eye Drops, Timolol 0.5% Eye Drops, Diclofenac 0.1% Eye Drops, Moxifloxacin Hydrochloride 0.5% Eye Drops, Prednisolone Acetate 1% Eye Drops, Olopatadine 0.1% Eye Drops, and others.

Company Info

GENIX PHARMACEUTICALS CORP

Suite 300, 1055 West Hastings St

Vancouver BRITISH COLUMBIA V6E 1J8 CA

CEO: Sina Salehi Pirooz

Employees: 0

GENX Company Website

GENX Investor Relations

Phone: 16046096198

GENIX PHARMACEUTICALS CORP / GENX.CA FAQ

Can you describe the business of GENIX PHARMACEUTICALS CORP?

Genix Pharmaceuticals Corp. engages in the the research, development, manufacture, licensing and sales of novel and innovative healthcare products, particularly proprietary over the counter nutraceuticals and generic pharmaceuticals. The company is headquartered in Vancouver, British Columbia. The firm is a formulator, manufacturer, licensor and marketer of life sciences-related products with a focus on nutraceuticals and pharmaceuticals. Its operations consist primarily of the research, development, manufacture, in-licensing and sales of novel and healthcare products, focusing on proprietary over the counter (OTC) nutraceuticals and generic pharmaceuticals. The firm has been marketing and selling other nutraceuticals and some pharmaceutical products, such as bee propolis capsules, calcium liquid softgels, seal oil softgels, marine lipid softgels, Lecithin softgels, fish oil softgels, EPO softgels and spirulina powder. Its products include Ketorolac 0.5% Eye Drops, Timolol 0.5% Eye Drops, Diclofenac 0.1% Eye Drops, Moxifloxacin Hydrochloride 0.5% Eye Drops, Prednisolone Acetate 1% Eye Drops, Olopatadine 0.1% Eye Drops, and others.


What is the current price of GENX stock?

The current stock price of GENX.CA is 0.03 CAD.


Does GENX stock pay dividends?

GENX.CA does not pay a dividend.


What is the ChartMill technical and fundamental rating of GENX stock?

GENX.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.


What is the GICS sector and industry of GENX stock?

GENIX PHARMACEUTICALS CORP (GENX.CA) operates in the Consumer Staples sector and the Personal Care Products industry.


How many employees does GENIX PHARMACEUTICALS CORP have?

GENIX PHARMACEUTICALS CORP (GENX.CA) currently has 0 employees.


Can you provide the market cap for GENIX PHARMACEUTICALS CORP?

GENIX PHARMACEUTICALS CORP (GENX.CA) has a market capitalization of 1.84M CAD. This makes GENX.CA a Nano Cap stock.


GENX.CA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

GENX.CA Financial Highlights


Industry RankSector Rank
PM (TTM) N/A
ROA -327.68%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%0%
Sales Q2Q%-100%
EPS 1Y (TTM)97.78%
Revenue 1Y (TTM)-97.5%

GENX.CA Forecast & Estimates


Analysts
Analysts0
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

GENX.CA Ownership

Ownership
Inst OwnersN/A
Ins Owners33.46%
Short Float %N/A
Short RatioN/A